Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Chronic kidney disease (CKD) is linked to increased cardiovascular morbidity and mortality.
• CKD patients exhibit a clustering of cardiovascular risk factors, including non-traditional ones like oxidative stress and inflammation.
• Oxidative stress and inflammation markers increase with declining renal function, suggesting they contribute to CKD progression and cardiovascular events.

Purpose of the Study:

• To investigate the role of oxidative stress and inflammation in cardiovascular complications of CKD.
• To explore the cardiovascular risk reduction associated with statin therapy in CKD patients.
• To understand the pleiotropic mechanisms of statins in mitigating cardiovascular risk in CKD.

Main Methods:

• Observational studies analyzing cardiovascular risk factors in CKD patients.
• Biochemical assays measuring oxidative stress and inflammatory markers in relation to renal function.
• Analysis of clinical trial data on statin use in CKD patients, focusing on cardiovascular events and pleiotropic effects.

Main Results:

• CKD is associated with elevated markers of oxidative stress and inflammation, even in early stages.
• Inflammatory markers and oxidative stress correlate with the severity of renal function deterioration.
• Statin administration significantly reduces major vascular events in high-risk CKD patients, attributed to both lipid-lowering and pleiotropic actions.

Conclusions:

• Oxidative stress and inflammation are key contributors to cardiovascular disease in CKD.
• Statins offer cardiovascular protection in CKD patients through mechanisms beyond lipid reduction, including modulation of oxidative stress and inflammation.
• Targeting oxidative stress and inflammation may be a crucial strategy for managing cardiovascular risk in CKD.